Loading clinical trials...
Loading clinical trials...
The purpose of this clinical research study is to learn if BMS-582664 can shrink or slow the growth of advanced liver cancer. The safety of this treatment will also be studied.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT07012798 · Hepatocellular Carcinoma (HCC)
NCT07322848 · Hepatocellular Carcinoma (HCC), TACE, and more
NCT07422753 · Hepatocellular Carcinoma (HCC)
NCT07493044 · Advanced Hepatocellular Carcinoma (HCC), GPC3 Positive Hepatocellular Carcinoma
NCT07052253 · Hepatocellular Carcinoma (HCC)
City Of Hope National Medical Center
Duarte, California
City Of Hope National Medical Center
Duarte, California
Harbor UCLA Medical Center
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions